Skip to main content
Sequana Medical N.V. logo

Sequana Medical N.V. — Investor Relations & Filings

Ticker · SEQUA ISIN · BE0974340722 LEI · 8755009AN12Y4PEOII07 BR Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2025-08-07 Share Issue/Capital Cha…
Country BE Belgium
Listing BR SEQUA

About Sequana Medical N.V.

https://www.sequanamedical.com/

Sequana Medical N.V. is a commercial-stage medical device company focused on developing treatments for drug-resistant fluid overload, a frequent complication in patients with liver disease, heart failure, and cancer. The company's primary product is the alfapump®, a fully implanted, wirelessly charged system that automatically and continuously removes ascites (fluid accumulation in the abdomen) into the bladder for natural elimination. It is the first U.S. FDA-approved active implantable medical device for treating recurrent or refractory ascites due to liver cirrhosis, designed to reduce or eliminate the need for therapeutic paracentesis. Sequana Medical is also advancing its DSR® (Direct Sodium Removal) therapy platform, a novel approach for managing fluid overload in heart failure patients.

Recent filings

Filing Released Lang Actions
20250807 Sequana Medical - GEM Subscription Notice PR (ENG).pdf
Share Issue/Capital Change Classification · 100% confidence The document is a press release from Sequana Medical announcing the issuance of a subscription request notice under an existing share subscription facility agreement with GEM. This involves the issuance of new shares to raise capital, which directly impacts the company's capital structure. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2025-08-07 English
20250807 Sequana Medical - GEM Subscription Notice PR (NL).pdf
Share Issue/Capital Change Classification · 100% confidence The document is a press release from Sequana Medical announcing the issuance of a subscription request notice under an existing share subscription facility agreement with GEM. This involves the creation of new shares and capital changes. According to the filing definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category. The document length is sufficient to be considered a primary announcement rather than a mere report publication notice.
2025-08-07 Dutch
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (28 July 2025).pdf
Major Shareholding Notification Classification · 100% confidence The document is a formal 'Transparency Notification' regarding a change in major shareholding (BlackRock/Kreos Capital crossing below the 5% threshold). This is a standard regulatory requirement for public companies to disclose significant changes in ownership. It fits the definition of a 'Major Shareholding Notification' (MRQ) as it details the specific entities, the number of shares/voting rights, and the threshold crossing event.
2025-07-28 English
Sequana Medical -- Transparency Notification PR BlackRock (NL) (28 July 2025).pdf
Major Shareholding Notification Classification · 100% confidence The document is a formal announcement regarding a change in shareholding structure (transparency notification) for Sequana Medical NV. It details that BlackRock and Kreos Capital have crossed a 5% threshold of voting rights. This type of filing is a standard regulatory requirement for major shareholding notifications. While it mentions the availability of the full transparency notice on the company website, the document itself serves as the official notification of the event, fitting the 'Major Shareholding Notification' category.
2025-07-28 Dutch
Sequana Medical - Loan Conversions -- Press Release (ENG) (22 July 2025).pdf
Share Issue/Capital Change Classification · 99% confidence The document is titled "SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES" and details a specific increase in share capital and the number of outstanding shares due to contributions in kind related to a convertible loan agreement. It also details the potential issuance of new shares upon the exercise of various share options and warrants. This content directly relates to changes in the company's capital structure and share issuance. This aligns perfectly with the definition of 'Share Issue/Capital Change' (Code: SHA). Although it is a press release, the core subject matter is the capital change itself, making SHA more specific than a general Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2025-07-22 English
Sequana Medical - Loan Conversions -- Press Release (NL) (22 July 2025).pdf
Share Issue/Capital Change Classification · 99% confidence The document is titled with a date and explicitly marked as 'PERSBERICHT GEREGLEMENTEERDE INFORMATIE' (Regulated Information Press Release). The core content details a capital increase ('kapitaal van de Vennootschap werd verhoogd') and the issuance of new shares due to the conversion of debt claims and outstanding options/warrants. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple dividend notice (DIV).
2025-07-22 Dutch

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.